Stone X Group Inc. Takeda Pharmaceutical CO LTD Transaction History

Stone X Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$13.17 - $16.4 $131,989 - $164,360	-10,022 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$16.3 - $17.26 $163,358 - $172,979	10,022 New	10,022 $164,000
Q2 2021 Aug 06, 2021	SELL	$16.55 - $18.64 $204,839 - $230,707	-12,377 Closed	0 $0
Q1 2021 Jun 30, 2021	BUY	$16.71 - $19.9 $206,819 - $246,302	12,377 New	12,377 $226,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.